Loading
Latest filing published 30 Jun 2020 for Translate Bio, Inc., €125.6M.
No signal scores available.
Only one filing by Shire Human Genetic Therapies, Inc. is known so far (30 June 2020): an open-market sale, €125.6M, in Translate Bio, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration